DK0390138T3 - Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel - Google Patents
Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddelInfo
- Publication number
- DK0390138T3 DK0390138T3 DK90106012.9T DK90106012T DK0390138T3 DK 0390138 T3 DK0390138 T3 DK 0390138T3 DK 90106012 T DK90106012 T DK 90106012T DK 0390138 T3 DK0390138 T3 DK 0390138T3
- Authority
- DK
- Denmark
- Prior art keywords
- antitumor agents
- platinum complexes
- contents
- active ingredient
- murine leukemia
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 2
- 150000003057 platinum Chemical class 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title 1
- 241001529936 Murinae Species 0.000 abstract 2
- 208000032839 leukemia Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010029155 Nephropathy toxic Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 abstract 1
- 229960004316 cisplatin Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 231100000226 haematotoxicity Toxicity 0.000 abstract 1
- 231100000417 nephrotoxicity Toxicity 0.000 abstract 1
- 230000007694 nephrotoxicity Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/36—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing at least two amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/02—Saturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/02—Saturated compounds containing hydroxy or O-metal groups
- C07C62/04—Saturated compounds containing hydroxy or O-metal groups with a six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1080917A JP2740919B2 (ja) | 1989-03-30 | 1989-03-30 | 白金錯体およびこれらを有効成分として含有する抗腫瘍剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0390138T3 true DK0390138T3 (da) | 1994-02-14 |
Family
ID=13731759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90106012.9T DK0390138T3 (da) | 1989-03-30 | 1990-03-29 | Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4968826A (ko) |
| EP (1) | EP0390138B1 (ko) |
| JP (1) | JP2740919B2 (ko) |
| KR (1) | KR950004896B1 (ko) |
| AT (1) | ATE99666T1 (ko) |
| AU (1) | AU623986B2 (ko) |
| CA (1) | CA2012155C (ko) |
| DE (1) | DE69005676T2 (ko) |
| DK (1) | DK0390138T3 (ko) |
| ES (1) | ES2062146T3 (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5206400A (en) * | 1986-07-07 | 1993-04-27 | Ohio State University | Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof |
| IT1216687B (it) * | 1988-04-01 | 1990-03-08 | Boehringer Biochemia Srl | Complessi di platino (ii), loro preparazione e impiego come antitumorali. |
| US5393909A (en) * | 1988-11-22 | 1995-02-28 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
| US5130450A (en) * | 1990-04-25 | 1992-07-14 | Nippon Kayaku Kabushiki Kaisha | Platinum complexes |
| JPH08176176A (ja) * | 1994-12-26 | 1996-07-09 | Ss Pharmaceut Co Ltd | 白金錯体及びこれを含有する悪性腫瘍治療剤 |
| US7208611B2 (en) * | 2005-02-23 | 2007-04-24 | Xenoport, Inc. | Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5829957B2 (ja) * | 1977-09-12 | 1983-06-25 | 喜徳 喜谷 | 新規な白金錯体 |
| JPS59112995A (ja) * | 1982-12-21 | 1984-06-29 | Shionogi & Co Ltd | 新規グリコ−ル酸白金錯体 |
| JPS617283A (ja) * | 1984-06-20 | 1986-01-13 | Shionogi & Co Ltd | 新規白金錯体および抗悪性腫瘍剤 |
| EP0169645A1 (en) * | 1984-06-27 | 1986-01-29 | Johnson Matthey Public Limited Company | Platinum co-ordination compounds |
| US4808730A (en) * | 1987-06-23 | 1989-02-28 | American Cyanamid Company | Synthesis of cisplatin analogs |
-
1989
- 1989-03-30 JP JP1080917A patent/JP2740919B2/ja not_active Expired - Fee Related
-
1990
- 1990-03-14 CA CA002012155A patent/CA2012155C/en not_active Expired - Fee Related
- 1990-03-16 US US07/495,169 patent/US4968826A/en not_active Expired - Lifetime
- 1990-03-29 ES ES90106012T patent/ES2062146T3/es not_active Expired - Lifetime
- 1990-03-29 DE DE69005676T patent/DE69005676T2/de not_active Expired - Fee Related
- 1990-03-29 EP EP90106012A patent/EP0390138B1/en not_active Expired - Lifetime
- 1990-03-29 AT AT90106012T patent/ATE99666T1/de not_active IP Right Cessation
- 1990-03-29 DK DK90106012.9T patent/DK0390138T3/da active
- 1990-03-30 KR KR1019900004351A patent/KR950004896B1/ko not_active IP Right Cessation
- 1990-03-30 AU AU52414/90A patent/AU623986B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2012155C (en) | 1995-11-07 |
| EP0390138B1 (en) | 1994-01-05 |
| DE69005676T2 (de) | 1994-06-01 |
| CA2012155A1 (en) | 1990-09-30 |
| US4968826A (en) | 1990-11-06 |
| KR900014415A (ko) | 1990-10-23 |
| KR950004896B1 (ko) | 1995-05-15 |
| AU5241490A (en) | 1990-10-04 |
| DE69005676D1 (de) | 1994-02-17 |
| JP2740919B2 (ja) | 1998-04-15 |
| AU623986B2 (en) | 1992-05-28 |
| ES2062146T3 (es) | 1994-12-16 |
| ATE99666T1 (de) | 1994-01-15 |
| EP0390138A1 (en) | 1990-10-03 |
| JPH02258790A (ja) | 1990-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE282630T1 (de) | Dolastatin-derivate | |
| ATE73814T1 (de) | Ammine-n-heterocyclische platinkomplexe und antitumormittel. | |
| DE69025230D1 (de) | 2,5-Diaryl-tetrahydrofurane und deren Analoge als PAF-Antagonisten | |
| DK0559079T3 (da) | Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne | |
| DE69001111D1 (de) | Antikrebs-zusammensetzung. | |
| DK0390138T3 (da) | Platinkomplekser og antitumormidler med indhold deraf som aktiv bestanddel | |
| DK74189A (da) | Laegemiddel til behandling af mavesaar | |
| DK0424899T3 (da) | Hidtil ukendte anthracyclinglycosidderivater og fremgangsmåde til fremstilling deraf | |
| DE3881862T2 (de) | Disaccharidderivate. | |
| NO904187D0 (no) | Benzanilider. | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| IL103417A0 (en) | Bis(phenyl)ethane derivatives,their preparation and pharmaceutical compositions containing them | |
| DK0538517T3 (da) | Nye organo-tinforbindelser med antitumoraktivitet og antitumormidler | |
| DE69601451T2 (de) | UCK14-Verbindungen | |
| DE69409553T2 (de) | Zytotoxische Verbindungen | |
| DK480389D0 (da) | Antitumorstof, fremgangsmaade til dets fremstilling og anticancermiddel indeholdende stoffet |